Callan Family Office »

Sana Biotechnology shares owned by Callan Family Office

Quarter-by-quarter ownership of Sana Biotechnology (SANA) shares owned by Callan Family Office from 13F filings

Historical chart of Callan Family Office investment in Sana Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Sana Biotechnology held by Callan Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sana Biotechnology by Callan Family Office

Quarter filed Position value Share count Share price at filing
2025-12-31 $65k 16k 4.07

More positions owned by Callan Family Office

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Ishares Tr Core Msci Eafe (IEFA)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Vanguard Scottsdale Fds Vng Rus3000idx (VTHR)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
Ishares Tr Rus 1000 Grw Etf (IWF)
Visa Com Cl A (V)

View all positions for Callan Family Office

Top funds holding Sana Biotechnology

FMR
Flagship Ventures Management
BlackRock
Vanguard Group
Canada Pension Plan Investment Board
State Street Corporation
Citadel Advisors
Baillie Gifford & Co
Geode Capital Management
Marex Group
Integral Health Asset Management
Alphabet
Jpmorgan Chase & Co
Baker Bros. Advisors
Renaissance Technologies

View all funds holding Sana Biotechnology